Literature DB >> 29752652

Disruption of the Responsible Gene in a Phosphoglucomutase 1 Deficiency Patient by Homozygous Chromosomal Inversion.

Katsuyuki Yokoi1,2, Yoko Nakajima1, Tamae Ohye2, Hidehito Inagaki2, Yoshinao Wada3, Tokiko Fukuda4, Hideo Sugie5, Isao Yuasa6, Tetsuya Ito1, Hiroki Kurahashi7,8,9.   

Abstract

Phosphoglucomutase 1 (PGM1) deficiency is a recently defined disease characterized by glycogenosis and a congenital glycosylation disorder caused by recessive mutations in the PGM1 gene. We report a case of a 12-year-old boy with first-cousin parents who was diagnosed with a PGM1 deficiency due to significantly decreased PGM1 activity in his muscle. However, Sanger sequencing revealed no pathogenic mutation in the PGM1 gene in this patient. As this case presented with a cleft palate in addition to hypoglycemia and elevated transaminases and creatine kinase, karyotyping was performed and identified homozygous inv(1)(p31.1p32.3). Based on the chromosomal location of the PGM1 gene at 1p31, we analyzed the breakpoint of the inversion. Fluorescence in situ hybridization (FISH) combined with long PCR analysis revealed that the inversion disrupts the PGM1 gene within intron 1. Since the initiation codon in the PGM1 gene is located within exon 1, we speculated that this inversion inactivates the PGM1 gene and was therefore responsible for the patient's phenotype. When standard molecular testing fails to reveal a mutation despite a positive clinical and biochemical diagnosis, the presence of a gross structural variant that requires karyotypic examination must be considered.

Entities:  

Keywords:  Chromosomal inversion; Congenital disorders of glycosylation; Hypoglycemia; PGM1; Phosphoglucomutase 1 deficiency

Year:  2018        PMID: 29752652      PMCID: PMC6323009          DOI: 10.1007/8904_2018_108

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  21 in total

1.  Muscle glycogenosis due to phosphoglucomutase 1 deficiency.

Authors:  Tanya Stojkovic; John Vissing; François Petit; Monique Piraud; Mette C Orngreen; Grete Andersen; Kristl G Claeys; Claire Wary; Jean-Yves Hogrel; Pascal Laforêt
Journal:  N Engl J Med       Date:  2009-07-23       Impact factor: 91.245

2.  Gene localisation of the PGM1 enzyme system and the Duffy blood groups on chromosome No. 1 by means of a new fragile site at 1p31.

Authors:  J Herbich; J Szilvassy; W Schnedl
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

3.  A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.

Authors:  Belén Pérez; Celia Medrano; Maria Jesus Ecay; Pedro Ruiz-Sala; Mercedes Martínez-Pardo; Magdalena Ugarte; Celia Pérez-Cerdá
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

4.  Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family.

Authors:  Pushpa Maliekal; Tatiana Sokolova; Didier Vertommen; Maria Veiga-da-Cunha; Emile Van Schaftingen
Journal:  J Biol Chem       Date:  2007-09-05       Impact factor: 5.157

Review 5.  Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.

Authors:  Lesa J Beamer
Journal:  J Inherit Metab Dis       Date:  2014-08-29       Impact factor: 4.982

6.  Multiple phenotypes in phosphoglucomutase 1 deficiency.

Authors:  Laura C Tegtmeyer; Stephan Rust; Monique van Scherpenzeel; Bobby G Ng; Marie-Estelle Losfeld; Sharita Timal; Kimiyo Raymond; Ping He; Mie Ichikawa; Joris Veltman; Karin Huijben; Yoon S Shin; Vandana Sharma; Maciej Adamowicz; Martin Lammens; Janine Reunert; Anika Witten; Esther Schrapers; Gert Matthijs; Jaak Jaeken; Daisy Rymen; Tanya Stojkovic; Pascal Laforêt; François Petit; Olivier Aumaître; Elzbieta Czarnowska; Monique Piraud; Teodor Podskarbi; Charles A Stanley; Reuben Matalon; Patricie Burda; Soraya Seyyedi; Volker Debus; Piotr Socha; Jolanta Sykut-Cegielska; Francjan van Spronsen; Linda de Meirleir; Pietro Vajro; Terry DeClue; Can Ficicioglu; Yoshinao Wada; Ron A Wevers; Dieter Vanderschaeghe; Nico Callewaert; Ralph Fingerhut; Emile van Schaftingen; Hudson H Freeze; Eva Morava; Dirk J Lefeber; Thorsten Marquardt
Journal:  N Engl J Med       Date:  2014-02-06       Impact factor: 91.245

7.  Compromised catalysis and potential folding defects in in vitro studies of missense mutants associated with hereditary phosphoglucomutase 1 deficiency.

Authors:  Yingying Lee; Kyle M Stiers; Bailee N Kain; Lesa J Beamer
Journal:  J Biol Chem       Date:  2014-10-06       Impact factor: 5.157

8.  Phosphoglucomutase-1 deficiency: Intrafamilial clinical variability and common secondary adrenal insufficiency.

Authors:  Neta Loewenthal; Alon Haim; Ruti Parvari; Eli Hershkovitz
Journal:  Am J Med Genet A       Date:  2015-08-19       Impact factor: 2.802

Review 9.  Congenital disorders of glycosylation: new defects and still counting.

Authors:  Kyle Scott; Therese Gadomski; Tamas Kozicz; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2014-05-15       Impact factor: 4.982

10.  Limitations of galactose therapy in phosphoglucomutase 1 deficiency.

Authors:  Kristine Nolting; Julien H Park; Laura C Tegtmeyer; Andrea Zühlsdorf; Marianne Grüneberg; Stephan Rust; Janine Reunert; Ingrid Du Chesne; Volker Debus; Eric Schulze-Bahr; Robert C Baxter; Yoshinao Wada; Christian Thiel; Emile van Schaftingen; Ralph Fingerhut; Thorsten Marquardt
Journal:  Mol Genet Metab Rep       Date:  2017-07-31
View more
  5 in total

Review 1.  Nutrition interventions in congenital disorders of glycosylation.

Authors:  Suzanne W Boyer; Christin Johnsen; Eva Morava
Journal:  Trends Mol Med       Date:  2022-05-10       Impact factor: 15.272

Review 2.  Genetic etiology and clinical challenges of phenylketonuria.

Authors:  Nasser A Elhawary; Imad A AlJahdali; Iman S Abumansour; Ezzeldin N Elhawary; Nagwa Gaboon; Mohammed Dandini; Abdulelah Madkhali; Wafaa Alosaimi; Abdulmajeed Alzahrani; Fawzia Aljohani; Ehab M Melibary; Osama A Kensara
Journal:  Hum Genomics       Date:  2022-07-19       Impact factor: 6.481

Review 3.  International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.

Authors:  Ruqaiah Altassan; Silvia Radenkovic; Andrew C Edmondson; Rita Barone; Sandra Brasil; Anna Cechova; David Coman; Sarah Donoghue; Kristina Falkenstein; Vanessa Ferreira; Carlos Ferreira; Agata Fiumara; Rita Francisco; Hudson Freeze; Stephanie Grunewald; Tomas Honzik; Jaak Jaeken; Donna Krasnewich; Christina Lam; Joy Lee; Dirk Lefeber; Dorinda Marques-da-Silva; Carlota Pascoal; Dulce Quelhas; Kimiyo M Raymond; Daisy Rymen; Malgorzata Seroczynska; Mercedes Serrano; Jolanta Sykut-Cegielska; Christian Thiel; Frederic Tort; Mari-Anne Vals; Paula Videira; Nicol Voermans; Peter Witters; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2020-09-15       Impact factor: 4.982

4.  Genome sequencing identifies a homozygous inversion disrupting QDPR as a cause for dihydropteridine reductase deficiency.

Authors:  Hardo Lilleväli; Sander Pajusalu; Monica H Wojcik; Julia Goodrich; Ryan L Collins; Ülle Murumets; Pille Tammur; Nenad Blau; Kersti Lilleväli; Katrin Õunap
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

5.  PGM1 and ENO1 Promote the Malignant Progression of Bladder Cancer via Comprehensive Analysis of the m6A Signature and Tumor Immune Infiltration.

Authors:  Jinglin Zhao; Shu Huang; Dingji Tan; Kaiqing Yang; Mingyue Chen; Xiongfei Jia; Xiaoqin Mao
Journal:  J Oncol       Date:  2022-02-24       Impact factor: 4.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.